Over 40% of nearly 8,600 US adults who had advanced hepatitis B–related liver disease appear to have received no treatment ...
Worldwide, seven drugs have been registered for the treatment of chronic hepatitis B. These include two interferons (conventional interferon and peginterferon alfa-2a) and five oral NAs (lamivudine, ...
Despite untreated HBV being linked to earlier mortality, higher all-cause and liver-related death, and a 10% to 25% lifetime risk of developing hepatocellular carcinoma (HCC), only 29% of qualifying ...
Working out of a tribal-owned hospital in Anchorage, Alaska, liver specialist Brian McMahon has spent decades treating the ...
With a $416,000 grant from the National Institutes of Health (NIH), SLU scientists will continue work to cure hepatitis B, building on significant findings published in two recent papers. John Tavis, ...
By Indication: Hepatitis B (HBV) vs. Hepatitis C (HCV) ...
A recall update has been published regarding a hepatitis B medication. The news comes as the Centers for Disease Control and Prevention (CDC) convenes to vote on updated guidelines for childhood ...
The World Health Organization (WHO) has released the Integrated drug resistance action framework for HIV, hepatitis B and C ...
The new chair of the Advisory Committee on Immunization Practices said the panel plans to vote to end universal hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback